Breath-based Diagnostics
Total Trials
14
As Lead Sponsor
9
As Collaborator
5
Total Enrollment
4,974
NCT03996590
Wessex Asthma Cohort of Difficult Asthma
Phase: N/A
Role: Collaborator
Start: Apr 22, 2015
Completion: Dec 31, 2050
NCT02612532
Lung Cancer Indicator Detection
Role: Lead Sponsor
Start: Oct 7, 2015
Completion: Dec 22, 2022
NCT03672994
Exhaled Breath Metabolomic Biomarkers in the Acutely Breathless Patient
Start: Feb 2, 2017
Completion: Apr 30, 2019
NCT03756597
PAN-study: Pan-Cancer Early Detection Study (PAN)
Start: Sep 26, 2018
Completion: Jul 6, 2023
NCT04106973
Mesothelioma Early Detection by VOCs
Start: Jun 5, 2019
Completion: Jan 1, 2022
NCT04467112
Non Inferiority Trial for Detection of nCOVID-19 Through Analysis of Exhaled Breath Aerosols
Start: Jul 30, 2020
Completion: Dec 19, 2020
NCT04508556
Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study
Start: Sep 30, 2020
NCT05510674
Safety and Dose Ranging Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution)
Phase: Phase 1
Start: Jul 6, 2021
Completion: Sep 20, 2023
NCT04301674
Metabolomics in Occupational Asthma
Start: Oct 15, 2021
Completion: Jun 1, 2023
NCT06193239
Diagnostic Accuracy Study for OWL-EVO1 As a Lung Cancer EVOC® Probe (Evolution Phase 2)
Phase: Phase 2
Start: Oct 5, 2023
Completion: Apr 30, 2025
NCT06344117
Assessment of Volatile Organic Compounds (VOC) for the Diagnosis of Invasive Aspergillosis (IA) in Lung Transplant Recipients
Start: Dec 12, 2023
Completion: Dec 31, 2025
NCT07035158
DELIVER Study in a Population With Clinical Suspicion of Liver Cirrhosis
Start: May 10, 2024
NCT05935488
Early Liver Disease Breath Detection
Start: May 21, 2024
Completion: Jun 30, 2024
NCT06476275
Single Dose Texas 2017 (H3N2) Challenge Study
Start: Sep 11, 2024
Completion: Feb 10, 2025
Loading map...